Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer

Authors

Robin L Jones, Royal Marsden Hospital
Thomas J Herzog, University of Cincinnati
Shreyaskumar R Patel, University of Texas MD Anderson Cancer Center
Margaret von Mehren, Fox Chase Cancer Center
Scott M Schuetze, University of Michigan - Ann Arbor
Brian A Van Tine, Washington University School of Medicine in St. Louis
Robert L Coleman, The Woodlands
Roland Knoblauch, Janssen Research & Development, LLC
Spyros Triantos, Janssen Research & Development, LLC
Peter Hu, Janssen Research & Development, LLC
Waleed Shalaby, Janssen Scientific Affairs, LLC
Tracy McGowan, Janssen Scientific Affairs, LLC
Bradley J Monk, University of Arizona
George D Demetri, Harvard University

Journal

Cancer Medicine

Publication Date

6-1-2021

Volume

10

Issue

11

First Page

3565

Last Page

3574

Document Type

Open Access Publication

DOI

10.1002/cam4.3903

Rights and Permissions

Jones, R.L., Herzog, T.J., Patel, S.R., von Mehren, M., Schuetze, S.M., Van Tine, B.A., Coleman, R.L., Knoblauch, R., Triantos, S., Hu, P., Shalaby, W., McGowan, T., Monk, B.J. and Demetri, G.D. (2021), Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer. Cancer Med, 10: 3565-3574. https://doi.org/10.1002/cam4.3903 © 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Jones, Robin L; Herzog, Thomas J; Patel, Shreyaskumar R; von Mehren, Margaret; Schuetze, Scott M; Van Tine, Brian A; Coleman, Robert L; Knoblauch, Roland; Triantos, Spyros; Hu, Peter; Shalaby, Waleed; McGowan, Tracy; Monk, Bradley J; and Demetri, George D, "Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer." Cancer Medicine. 10, 11. 3565 - 3574. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10739